Voting Results of Cosmo's 2026 AGM

Rhea-AI Summary

Cosmo Pharmaceuticals (CMOPF) reported that shareholders approved all items at the Ordinary Annual General Meeting on April 10, 2026.

10,354,065 ordinary shares were represented, equal to 59.02% of outstanding ordinary shares. Shareholders approved a €2.10 per share dividend; ex-dividend date is 24 April 2026 and payment date is 11 May 2026.

Positive

• Dividend approved at €2.10 per share
• Shareholder approval of all AGM voting items
• Meeting turnout of 10,354,065 shares (59.02%)

Negative

• None.

News Market Reaction – CMOPF

+2.04%

1 alert

+2.04% News Effect

On the day this news was published, CMOPF gained 2.04%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Dublin, Ireland--(Newsfile Corp. - April 10, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced that its shareholders approved all voting items at today’s Ordinary Annual General Meeting (AGM). A total of 10,354,065 ordinary shares of the share capital of Cosmo were represented at this general meeting of shareholders. These shares make up 59.02% of the total outstanding ordinary shares in the share capital of Cosmo as of the record date.

Among others, the shareholders of Cosmo approved a dividend of €2.10 per share. The ex-dividend date will be 24 April 2026, and payment will be made on 11 May 2026. The full voting results of the 2026 AGM and detailed dividend payment information are available on the Company’s website via www.cosmohealthconfidence.com/agm.  

About Cosmo

Cosmo is a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). We design, develop, and manufacture advanced solutions that address critical medical needs and raise the standard of care. Our technologies are trusted by leading global pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. Guided by our purpose - Building Health Confidence - our mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, with offices in San Diego (USA), and in Lainate, Rome, and Catania (Italy). For more information, visit www.cosmohealthconfidence.com.

For further information, please contact:

investor.relations@cosmohc.com

Attachments

PDF - English

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/291920

FAQ

What dividend did Cosmo (CMOPF) approve at the April 10, 2026 AGM?

Cosmo approved a dividend of €2.10 per share. According to the company, the dividend was approved by shareholders at the 2026 AGM and will be paid to recordholders per the announced schedule.

When is the ex-dividend date and payment date for Cosmo (CMOPF) dividend?

The ex-dividend date is 24 April 2026 and payment is on 11 May 2026. According to the company, eligible shareholders must hold shares before the ex-dividend date to receive the May payment.

How many shares and what turnout were represented at Cosmo's April 10, 2026 AGM (CMOPF)?

A total of 10,354,065 ordinary shares were represented, equal to 59.02% of outstanding ordinary shares. According to the company, this figure reflects shareholder participation as of the record date.

Did Cosmo (CMOPF) pass all proposals at its 2026 AGM?

Yes, shareholders approved all voting items at the Ordinary AGM on April 10, 2026. According to the company, every resolution presented to shareholders received the required approval.

Where can investors find full voting results and dividend details for Cosmo (CMOPF)?

Full voting results and detailed dividend payment information are available on Cosmo's investor site. According to the company, the AGM materials and payment instructions are published on its website for investors to review.